1177269-06-5

Basic information

• Product Name: 2-bromo-5-(cyclopropylmethoxy)Pyridine
• Synonyms: 2-bromo-5-(cyclopropylmethoxy)Pyridine
• CAS NO: 1177269-06-5
• Molecular Formula: C₉H₁₀BrNO
• Molecular Weight: 228.0858
• Mol File: 1177269-06-5.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 2-bromo-5-(cyclopropylmethoxy)Pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-bromo-5-(cyclopropylmethoxy)Pyridine(1177269-06-5)
• EPA Substance Registry System: 2-bromo-5-(cyclopropylmethoxy)Pyridine(1177269-06-5)

Safety Data

• Hazardous Substances Data: 1177269-06-5(Hazardous Substances Data)

Usage

General Description

2-bromo-5-(cyclopropylmethoxy)Pyridine is an organic compound that belongs to the pyridine family. It is a derivative of pyridine with a bromine atom at the 2-position and a cyclopropylmethoxy group at the 5-position. 2-bromo-5-(cyclopropylmethoxy)Pyridine is commonly used as a building block in organic synthesis and pharmaceutical research. It can also be used as an intermediate in the production of various pharmaceuticals and agrochemicals. 2-bromo-5-(cyclopropylmethoxy)Pyridine is known for its potential as a versatile reagent in organic chemistry, with applications in the synthesis of complex molecules.

Upstream product

• 55717-45-8 6-bromo-pyridin-3-ol 
• 7051-34-5 cyclopropylcarbinyl bromide 

Downstream Products

• 1380069-79-3 4-[6-(cyclopropylmethoxy)imidazo[1,2-a]pyridin-2-yl]phenol 
• 1380069-82-8 tert-butyl [(1S)-2-(4-{[5-(cyclopropylmethoxy)pyridin-2-yl]ethynyl}phenoxy)-1-methylethyl]carbamate 
• 1380069-83-9 tert-butyl [(1S)-2-{4-[6-(cyclopropylmethoxy)pyrazolo[1,5-a]pyridin-2-yl]phenoxy}-1-methylethyl]carbamate 
• 1380069-89-5 2-[4-(benzyloxy)phenyl]-6-(cyclopropylmethoxy)[1,2,4]triazolo[1,5-a]pyridine 
• 1380070-08-5 tert-butyl [(1S)-2-{4-[6-(cyclopropylmethoxy)pyrazolo[1,5-a]pyridin-2-yl]-3-fluorophenoxy}-1-methylethyl]carbamate 
• 1380070-09-6 tert-butyl [(1S)-2-{4-[6-(cyclopropylmethoxy)-3-fluoropyrazolo[1,5-a]pyridin-2-yl]-3-fluorophenoxy}-1-methylethyl]carbamate 
• 1380067-72-0 N-[(1S)-2-{4-[6-(cyclopropylmethoxy)-3-fluoropyrazolo[1,5-a]pyridin-2-yl]-3-fluorophenoxy}-1-methylethyl]acetamide 
• 1380067-73-1 1-[(1S)-2-{4-[6-(cyclopropylmethoxy)-3-fluoropyrazolo[1,5-a]pyridin-2-yl]-3-fluorophenoxy}-1-methylethyl]urea 
• 1380067-74-2 N-[(1S)-2-{4-[6-(cyclopropylmethoxy)pyrazolo[1,5-a]pyridin-2-yl]-3-fluorophenoxy}-1-methylethyl]acetamide 
• 1380067-75-3 N-[(1S)-2-{4-[6-(cyclopropylmethoxy)pyrazolo[1,5-a]pyridin-2-yl]-3-fluorophenoxy}-1-methylethyl]urea 
• 1380070-35-8 tert-butyl [(1S)-2-{4-[6-(cyclopropylmethoxy)pyrazolo[1,5-a]pyridin-2-yl]-3,5-difluorophenoxy}-1-methylethyl]carbamate 
• 1380070-31-4 N-[(1S)-2-{4-[6-(cyclopropylmethoxy)pyrazolo[1,5-a] pyridin-2-yl]-3,5-difluorophenoxy}-1-methylethyl]acetamide 
• 1380070-07-4 tert-butyl [(1S)-2-(4-{[5-(cyclopropylmethoxy)pyridin-2-yl]ethynyl}-3-fluorophenoxy)-1-methylethyl]carbamate 
• 1380070-34-7 tert-butyl [(1S)-2-(4-{[5-(cyclopropylmethoxy)pyridin-2-yl]ethynyl}-3,5-difluorophenoxy)-1-methylethyl]carbamate 

Relevant articles and documents

PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

The invention relates to new pyrrolidine derivatives of the formula (I), to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.

Spiro Compounds As NPY Y5 Receptor Antagonists

The present invention relates to novel compounds of formula (I), or a pharmaceutically acceptable salt thereof, wherein R is an aryl or heteroaryl, which may be substituted by one or more: halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, cyano;Z1 is H, C1-C4 alkyl or F;Z is CH2, CH(C1-C4 alkyl), C(C1-C4 alkyl)2 or a bond;A is a 6-10 membered aryl or heteroaryl, which may be substituted by one or more: halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, cyano; or —C(═O)—X; or —O(CH2)0-1R1;B is hydrogen or is a 5-6 membered heteroaryl, or a 4-6 membered heterocycle, or phenyl, which may be substituted by one or more: halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, hydroxyl, cyano; A and B being linked via any atom;R1 is —(C1-C4)alkyl(C1-C4)alkoxy; or C3-C8 cycloalkyl; or R1 is an aryl or heteroaryl, which may be substituted by one or more: halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, cyano; or R1 is a 4-6 membered heterocycle, which may be substituted by one or more: halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, cyano;X is OR2 or NR3R4;R2 is C1-C4 alkyl;R3 is hydrogen or together with R4 and the nitrogen form a 5-6 saturated membered ring;R4 is C3-C8 cycloalkyl; processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing them and their use in therapy, as NPY Y5 receptor antagonists and as agents for the treatment and/or prophylaxis of eating disorders such as a binge eating disorder.